IPDQF 0.04 ImpediMed Limited
| Range: | 0.025-0.11 | Vol Avg: | 7148 | Last Div: | 0 | Changes: | -0.03 |
| Beta: | 2.86 | Cap: | 0.13B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Sep 25 2012 | Empoloyees: | 83 | ||
| CUSIP: | CIK: | ISIN: | AU000000IPD8 | Country: | AU | ||
| CEO: | Dr. Parmjot Bains M.D. | Website: | https://www.impedimed.com | ||||
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow